Overcome Trust Issues To Solve The Patient Diversity Problem

Source: Clinical Leader

Patient diversity remains a problem in clinical trials. Although FDA-approved medicines serve a diverse population of Americans, participation in clinical trials remains predominantly white and male. 

In this webinar segment, Robin Weinick, SVP & Managing Director, Americas and Global Program Officer for DIA, discusses the role played by our healthcare system. Americans in different states, cities, and communities do not have access to the same levels of healthcare. That discrepancy can lead to a distrust of physicians, insurers, health centers, and drug developers. Sponsors must overcome trust issues if they are to solve the patient diversity problem. Weinick discusses the lack of trust in the process, the Tuskegee experiments, and why communication is critical to overcoming these trust issues.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader